Press release
Chimeric Antigen Receptor T (CAR-T) Cells Market Research Analysis, Application And Forecast To 2033
Chimeric Antigen Receptor T (CAR-T) Cells Market
The Business Research Company offers in-depth market insights through Chimeric Antigen Receptor T (CAR-T) Cells Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The chimeric antigen receptor t (car-t) cells market size has grown exponentially in recent years. It will grow from $2.76 billion in 2023 to $3.89 billion in 2024 at a compound annual growth rate (CAGR) of 40.9%. . The growth in the historic period can be attributed to breakthrough fda approvals, successful clinical trials and patient outcomes, advances in gene editing techniques, growing investment from pharmaceutical companies, rising incidence of cancer .
The chimeric antigen receptor t (car-t) cells market size is expected to see exponential growth in the next few years. It will grow to $14.35 billion in 2028 at a compound annual growth rate (CAGR) of 38.5%. . The growth in the forecast period can be attributed to regulatory streamlining, the exploration of car-t therapy, market expansion in emerging economies, personalized medicine adoption, awareness and education. Major trends in the forecast period include off-the-shelf car-t therapies, combination therapies, technological advancements, long-term safety and efficacy, advancements in manufacturing.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=8124&type=smp
Market Segmentation:
The chimeric antigen receptor t (car-t) cells market covered in this report is segmented -
1) By Target Antigen: CD19, CD22, Other Antigens
2) By Application: Acute Lymphoblastic Leukaemia, Diffuse Large B-Cell Lymphoma, Other Applications
3) By End User: Hospitals, Cancer Research Centres, Clinics
Major Driver - Rising Cancer Occurrence Drives Growth In Chimeric Antigen Receptor T (CAR-T) Cells Market
The increasing occurrence of cancer is driving the chimeric antigen receptor T (CAR-T) cells market. Cancer is a chronic disease in which normal body cells divide and grow without any control and affect the nearest body tissue and turn into tumors cells. The chimeric antigen receptor T (CAR-T) cells are used to treat various types of cancers such as hematological malignancies, including acute lymphoblastic leukemia, chronic lymphocytic and can also treat solid tumors such as breast cancer and sarcoma. For instance, in 2021, according to the American Cancer Society, a voluntary health organization, global cancer patients diagnosed is expected to reach 1.9 million in 2021. Due to population increase and age, the worldwide burden of cancer is predicted to reach 27.5 million new cases and 16.2 million cancer deaths by 2040. Therefore, the rising prevalence of cancer disease is anticipated to boost the chimeric antigen receptor T (CAR-T) cells market in the upcoming years.
Competitive Landscape:
Major companies operating in the chimeric antigen receptor T (CAR-T) cells market report are Novartis International AG, Pfizer Inc, Kite Pharma, Autolus Therapeutics Plc, CARsgen Therapeutics Company Limited, Bristol-Myers Squibb Company, Legend Biotech, Mustang Bio Inc, Bluebird Bio Inc, Legend Biotech, Allogene Therapeutics, Atara Biotherapeutics, Bellicum Pharmaceuticals, Carisma Therapeutics, TCR² Therapeutics.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/chimeric-antigen-receptor-t-car-t-cells-global-market-report
Top Trend - Innovative Product Developments In Chimeric Antigen Receptor T (CAR-T) Cells Market
Product innovation is a key trend gaining popularity in the chimeric antigen receptor T (CAR-T) cells market. Major market players operating in the chimeric antigen receptor T (CAR-T) cells market are concentrating their efforts on creating innovative technologies to develop novel CAR-T cell-based treatments. For instance, in December 2021, Novartis AG, a Switzerland-based pharmaceutical company specializing in the development and manufacturing of drugs launched the T-Charge CAR-T platform. This technology-enabled platform enables the self to renew and maturation CAR-T cells offering a greater proliferative environment for cells.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Chimeric Antigen Receptor T (CAR-T) Cells Market Characteristics
3. Chimeric Antigen Receptor T (CAR-T) Cells Market Trends And Strategies
4. Chimeric Antigen Receptor T (CAR-T) Cells Market - Macro Economic Scenario
5. Chimeric Antigen Receptor T (CAR-T) Cells Market Size And Growth
…..
27. Chimeric Antigen Receptor T (CAR-T) Cells Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chimeric Antigen Receptor T (CAR-T) Cells Market Research Analysis, Application And Forecast To 2033 here
News-ID: 3413175 • Views: …
More Releases from The Business research company
Emerging Innovations Set to Redefine the Sewer Rehabilitation Services Market La …
How Large Is the Sewer Rehabilitation Services Market Anticipated to Become by 2025?
The global market for sewer rehabilitation services has experienced robust expansion lately, projected to increase from a valuation of $42.38 billion in 2024 to $45.14 billion in the subsequent year, reflecting a compound annual growth rate (CAGR) of 6.5%. This historical upward trajectory is primarily fueled by several key factors: escalating levels of urbanization, the ever-aging condition of…
2025-2034 Sea Based C4ISR Market Outlook: Emerging Drivers, Growth Barriers, and …
What Market Size Will the Sea Based C4ISR Sector Reach by 2025?
The maritime C4ISR market experienced substantial expansion lately, projected to climb from a value of $3.0 billion in 2024 to $3.17 billion the following year, reflecting a compound annual growth rate of 5.7%. This upward trend observed over the historical period stems from several factors, including the intensification of naval modernization initiatives, escalating maritime security perils, augmentation in defense…
The Impact of Rapid Urbanization on the Ripening Culture Market: A Key Force Sha …
What Is the Forecasted Size of the Ripening Culture Market by 2025?
The market for ripening cultures has experienced substantial expansion lately, projected to increase from a valuation of $1.46 billion in 2024 to $1.57 billion a year later, demonstrating a consistent yearly growth rate (CAGR) of 7.7%. This upward trajectory during the past period stems from several key factors, including heightened demand for fermented dairy items, greater recognition of the…
Strong Demand Anticipated to Drive Recirculating Chillers Market Toward $2.76 Bi …
How Much Expansion Is Expected in the Recirculating Chillers Market by 2025?
The market encompassing recirculating chillers has seen swift expansion lately, projected to escalate from a value of $1.65 billion in 2024 to $1.83 billion by the ensuing year, reflecting an impressive compound annual growth rate (CAGR) of 11.2%. This upward trajectory during the historical timeframe stems from several factors, including the proliferation of automated systems in industrial procedures, escalating…
More Releases for Antigen
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth: Cr …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Carcinoembryonic Antigen Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market encompassing carcinoembryonic antigen has experienced swift expansion lately, projected to progress from a valuation of $1.22 billion in 2024 to $1.38 billion the following year, reflecting a robust compound annual growth rate of…
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth: A …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Carcinoembryonic Antigen Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The size of the carcinoembryonic antigen market has experienced swift growth in the previous years. There will be an increase from $1.22 billion in 2024 to $1.38 billion in 2025, exhibiting a compound annual growth…
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth Dri …
What combination of drivers is leading to accelerated growth in the carcinoembryonic antigen market?
The surge in cancer cases is anticipated to fuel the expansion of the carcinoembryonic antigen market in the future. Cancer is an ailment identified by unregulated proliferation and dissemination of irregular cells. The prevalence of cancer is increasing owing to aspects such as lifestyle alternatives, environmental contamination, genetic susceptibility, and a growing elderly population. Carcinoembryonic antigen (CEA)…
COVID-19 Antigen Test Market Report 2024 - COVID-19 Antigen Test Market Growth A …
"The Business Research Company recently released a comprehensive report on the Global COVID-19 Antigen Test Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, the covid-19 antigen…
COVID-19 Antigen Test Market Report 2024 - COVID-19 Antigen Test Market Size And …
"The Business Research Company recently released a comprehensive report on the Global COVID-19 Antigen Test Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The covid-19 antigen…
CEACAM8 Antigen Gene Market Unveiling the Enigma: The CEACAM8 Antigen Gene Marke …
CEACAM8 Antigen Gene Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global CEACAM8 Antigen Gene Market Size, Share & Trends Analysis Report By Type (Above 95%, Above 99%, Others), By Application (Biopharmaceutical Companies, Hospitals, Bioscience Research Institutions, Others)- Market Outlook And Industry Analysis 2031"
The Global CEACAM8 Antigen Gene Market is estimated…
